NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Excerpt
Chronic ulcers (i.e., ulcers that are unresponsive to initial therapy or that persist despite appropriate care) are estimated to affect over 6 million people in the United States. The incidence is expected to increase as the population ages and as the number of individuals with diabetes increases. Chronic ulcers negatively affect the quality of life and productivity of the patient and represent a substantial financial burden to the health care system.
Lower extremity ulcers, especially those attributed to either diabetes, venous disease, or arterial disease comprise a substantial proportion of chronic ulcers. Approximately 15% to 25% of individuals with diabetes develop a foot ulcer at some point in their lifetime and an estimated 12% of those patients require lower extremity amputation. Healing is complicated by diabetic neuropathy and susceptibility to infection. Venous disease accounts for the majority of chronic lower extremity ulcers. Venous hypertension secondary to various cuases results in damage to vessel walls and ultimately leads to skin breakdown. Arterial ulcers are less common and are a result of impaired circulation which can affect healing lead to ulceration.
Standard treatment for diabetic ulcers includes debridement of necrotic tissue, infection control, local ulcer care, mechanical off-loading, management of blood glucose levels, and education on foot care. For venous ulcers, standard treatment typically includes the use of mechanical compression and limb elevation to reverse tissue edema and improve venous blood flow. Care for ulcers caused by arterial insufficiency is centered on reestablishing blood flow and minimizing further loss of tissue perfusion.
If ulcers do not adequately heal with standard treatment, additional modalities may be required – these are often termed “advanced wound care therapies.” Lower extremity ulcers are frequently classified etiologically as diabetic, venous or arterial, though overlap may exist. Treatment modalities and wound care therapies are often selected based on the ulcer characteristics as well as patient factors, past treatment, and provider preference. A large and growing array of advanced wound care therapies of different composition and indications have been developed though their efficacy, comparative effectiveness and harm is not well established.
The purpose of this review is to synthesize the evidence on therapies for non-healing diabetic, venous, and arterial lower extremity ulcers. This work was nominated by Rajiv Jain, MD (Chief Consultant, Office of Patient Care Services) and Jeffrey Robbins, DPM (Director, Podiatry Service) and is intended to provide an evidence base to guide clinical practice and policy needs within the VA. We recognize that a non-healing ulcer is likely a result of multiple factors and comorbid conditions. We group studies in the review according to the study authors' description of the included ulcer type. The review focuses on FDA-approved therapies and examines clinically relevant outcomes.
Contents
- PREFACE
- EXECUTIVE SUMMARY
- INTRODUCTION
- METHODS
- RESULTS
- LITERATURE FLOW
- KEY QUESTION #1 What are the efficacy and harms of therapies for diabetic ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?
- KEY QUESTION #2 What are the efficacy and harms of therapies for venous ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?
- KEY QUESTION #3 What are the efficacy and harms of therapies for arterial ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?
- SUMMARY AND DISCUSSION
- REFERENCES
- APPENDIX A THERAPY DESCRIPTIONS AND REFERENCES
- APPENDIX B SEARCH STRATEGY
- APPENDIX C PEER REVIEW COMMENTS/AUTHOR RESPONSES
- APPENDIX D EVIDENCE TABLES
- APPENDIX E COMMON METHODOLOGICAL ERRORS AND RECOMMENDATIONS FOR FUTURE CLINICAL TRIALS OF WOUND HEALING
Prepared for: Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Minneapolis VA Medical Center, Minneapolis, MN, Timothy J. Wilt, M.D., M.P.H., Director
Suggested citation:
Greer N, Foman N, Dorrian J, Fitzgerald P, MacDonald R, Rutks I, Wilt T. Advanced Wound Care Therapies for Non-Healing Diabetic, Venous, and Arterial Ulcers: A Systematic Review. VA-ESP Project #09-009; 2012.
This report is based on research conducted by the Evidence-based Synthesis Program (ESP) Center located at the Minneapolis VA Medical Center, Minneapolis, MN funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative. The findings and conclusions in this document are those of the author(s) who are responsible for its contents; the findings and conclusions do not necessarily represent the views of the Department of Veterans Affairs or the United States government. Therefore, no statement in this article should be construed as an official position of the Department of Veterans Affairs. No investigators have any affiliations or financial involvement (e.g., employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in the report.
- NLM CatalogRelated NLM Catalog Entries
- Review Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.[Health Technol Assess. 2000]Review Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.O'Meara S, Cullum N, Majid M, Sheldon T. Health Technol Assess. 2000; 4(21):1-237.
- Diagnosis and treatment of diabetic foot infections.[Plast Reconstr Surg. 2006]Diagnosis and treatment of diabetic foot infections.Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, et al. Plast Reconstr Surg. 2006 Jun; 117(7 Suppl):212S-238S.
- Review Cost-effective management of recalcitrant diabetic foot ulcers.[Clin Podiatr Med Surg. 2002]Review Cost-effective management of recalcitrant diabetic foot ulcers.Albert S. Clin Podiatr Med Surg. 2002 Oct; 19(4):483-91.
- Review Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review.[Ann Intern Med. 2013]Review Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review.Greer N, Foman NA, MacDonald R, Dorrian J, Fitzgerald P, Rutks I, Wilt TJ. Ann Intern Med. 2013 Oct 15; 159(8):532-42.
- Review Diabetic Foot Ulcers: A Review.[JAMA. 2023]Review Diabetic Foot Ulcers: A Review.Armstrong DG, Tan TW, Boulton AJM, Bus SA. JAMA. 2023 Jul 3; 330(1):62-75.
- Advanced Wound Care Therapies for Non-Healing Diabetic, Venous, and Arterial Ulc...Advanced Wound Care Therapies for Non-Healing Diabetic, Venous, and Arterial Ulcers: A Systematic Review
- Interventions to Improve Veterans' Access to CareInterventions to Improve Veterans' Access to Care
Your browsing activity is empty.
Activity recording is turned off.
See more...